Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for severe early-onset intrauterine growth restriction
ISRCTN39133303Phase 3Completed
- Sponsor
- Liverpool Women's NHS Foundation Trust
- Start
- Aug 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in intrauterine growth restriction (IUGR) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Mean randomization-to-birth interval. Started Aug 2014; status: completed.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on ISRCTN39133303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN39133303.